* HAVEN 2 study: HAVEN 2 study is a multicenter
, open-label, phase III study in children younger than 12 years of age with hemophilia A with factor VIII inhibitors.
IOR08 Clinically Meaningful Responses to Fremanezumab in Patients With Migraine and Documented Inadequate Response to 2-4 Classes Of Migraine Preventive Medications in the Multicenter
, Randomized, Placebo-Controlled FOCUS Study
In patients with metastatic breast cancer, tesetaxel was shown to have significant, single-agent antitumor activity in two multicenter
, Phase 2 studies.
(2) aimed to evaluate the long-term outcomes and reproducibility of ESG and the predictors of weight response in a large multicenter
* create an environment for fellows to participate in collaborative research and conduct multicenter
studies as primary investigators
But a larger, multicenter
study found no difference between 43 hospitals with laborists and 139 without laborists on a range of outcomes, including the primary cesarean delivery rate (13.9% vs.
The RGI-2001 study is a randomized, open-label, multicenter
Phase 2 study being conducted in patients undergoing allogeneic hematopoietic stem cell transplantation (AHSCT).
clinical trial was funded by the National Institute on Deafness and Other Communication Disorders (NIDCD), part of the National Institutes of Health.
In this multicenter
study (29 centers, 5 countries), we included 267 patients who underwent primary coronary intervention within 6 hours of onset of symptoms.
of Arizona Health Science Center) compile chapters by neurologists, neuroscientists, and other researchers from the US and France, who discuss animal models of various neurological diseases, FDA and European requirements, translation and scaling up from animal to human studies, the design of phase I, II, III, and multicenter
trials, and the use of biomarkers as surrogate endpoints.
Radiofrequency ablation (RFA) has been found to generate a complete response in a high percentage of patients in an industry-sponsored, prospective, single-arm, multicenter
trial involving patients with early-stage non-small cell lung cancer (NSCLC) or pulmonary metastases (overall tumor size < 3.5 cm; median size = 1.5 cm; total number of tumors in both groups = 183), who were ineligible for surgery, standard radiotherapy, or chemotherapy.
These are the key findings of a secondary analysis of data from a multicenter
study comparing the effectiveness and safety of misoprostol and vacuum aspiration for the treatment of early pregnancy failure.